Julia Jill K Warnock

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. ncbi Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment
    Julia Jill K Warnock
    University of Oklahoma Health Sciences Center Tulsa, Tulsa, Oklahoma 74135 2512, USA
    CNS Drugs 16:745-53. 2002
  2. ncbi Chronic episodic disorders in women
    Julia K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center Tulsa, 4502 East 41st Street, Tulsa, OK 74135 2553, USA
    Psychiatr Clin North Am 26:725-40. 2003
  3. ncbi Female hypoactive sexual disorder: case studies of physiologic androgen replacement
    J K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center, Tulsa 74129, USA
    J Sex Marital Ther 25:175-82. 1999
  4. ncbi Depressive mood symptoms associated with ovarian suppression
    J K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, 74135, USA
    Fertil Steril 74:984-6. 2000
  5. ncbi Adverse cutaneous reactions to antidepressants
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, Oklahoma 74135, USA
    Am J Clin Dermatol 3:329-39. 2002
  6. ncbi Adverse cutaneous reactions to antipsychotics
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa 74135, USA
    Am J Clin Dermatol 3:629-36. 2002
  7. ncbi Adverse cutaneous reactions to mood stabilizers
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, Oklahoma 74135, USA
    Am J Clin Dermatol 4:21-30. 2003
  8. ncbi Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women
    Julia K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center, Tulsa, OK 74135, USA
    Menopause 12:374-84. 2005

Detail Information

Publications8

  1. ncbi Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment
    Julia Jill K Warnock
    University of Oklahoma Health Sciences Center Tulsa, Tulsa, Oklahoma 74135 2512, USA
    CNS Drugs 16:745-53. 2002
    ..Clinical trials are presently underway to assess medications that may potentially benefit female patients with HSDD...
  2. ncbi Chronic episodic disorders in women
    Julia K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center Tulsa, 4502 East 41st Street, Tulsa, OK 74135 2553, USA
    Psychiatr Clin North Am 26:725-40. 2003
    ..Thus, an increased understanding of the CED may result in improved treatment and functioning of many patients...
  3. ncbi Female hypoactive sexual disorder: case studies of physiologic androgen replacement
    J K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center, Tulsa 74129, USA
    J Sex Marital Ther 25:175-82. 1999
    ..0 pg/ml are presented. Physiologic androgen replacement is helpful in increasing sexual desire for some women...
  4. ncbi Depressive mood symptoms associated with ovarian suppression
    J K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, 74135, USA
    Fertil Steril 74:984-6. 2000
    ..To determine if sertraline is helpful in the management of depressive symptoms associated with ovarian suppression during GnRH agonist therapy as compared with a placebo-controlled group...
  5. ncbi Adverse cutaneous reactions to antidepressants
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, Oklahoma 74135, USA
    Am J Clin Dermatol 3:329-39. 2002
    ....
  6. ncbi Adverse cutaneous reactions to antipsychotics
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa 74135, USA
    Am J Clin Dermatol 3:629-36. 2002
    ..If the reaction is mild, and the therapeutic benefits far exceed the risks of the symptomatic treatment, then the antipsychotic agent may be continued...
  7. ncbi Adverse cutaneous reactions to mood stabilizers
    Julia K Warnock
    University of Oklahoma Health Sciences Center, Tulsa, Oklahoma 74135, USA
    Am J Clin Dermatol 4:21-30. 2003
    ..Patients should also be advised to seek medical attention if they suspect a drug-induced skin reaction. If the physician suspects a severe ACDR, the offending agent should be removed immediately...
  8. ncbi Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women
    Julia K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center, Tulsa, OK 74135, USA
    Menopause 12:374-84. 2005
    ..To compare the effect of esterified estrogens and methyltestosterone versus esterified estrogens alone on diminished sexual interest in surgically menopausal women...